Details for New Drug Application (NDA): 205065
✉ Email this page to a colleague
NDA 205065 describes KUVAN, which is a drug marketed by Biomarin Pharm and is included in two NDAs. It is available from one supplier. There are three patents protecting this drug and three Paragraph IV challenges. Additional details are available on the KUVAN profile page.
The generic ingredient in KUVAN is sapropterin dihydrochloride. There are three drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sapropterin dihydrochloride profile page.
The generic ingredient in KUVAN is sapropterin dihydrochloride. There are three drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sapropterin dihydrochloride profile page.
Summary for 205065
| Tradename: | KUVAN |
| Applicant: | Biomarin Pharm |
| Ingredient: | sapropterin dihydrochloride |
| Patents: | 1 |
Suppliers and Packaging for NDA: 205065
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| KUVAN | sapropterin dihydrochloride | POWDER;ORAL | 205065 | NDA | BioMarin Pharmaceutical Inc. | 68135-301 | 68135-301-22 | 30 PACKET in 1 CARTON (68135-301-22) / 1 POWDER, FOR SOLUTION in 1 PACKET (68135-301-11) |
| KUVAN | sapropterin dihydrochloride | POWDER;ORAL | 205065 | NDA | BioMarin Pharmaceutical Inc. | 68135-482 | 68135-482-11 | 30 PACKET in 1 CARTON (68135-482-11) / 1 POWDER, FOR SOLUTION in 1 PACKET (68135-482-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;ORAL | Strength | 100MG/PACKET | ||||
| Approval Date: | Dec 19, 2013 | TE: | AB | RLD: | Yes | ||||
| Patent: | ⤷ Get Started Free | Patent Expiration: | May 1, 2033 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;ORAL | Strength | 500MG/PACKET | ||||
| Approval Date: | Oct 27, 2015 | TE: | AB | RLD: | Yes | ||||
| Patent: | ⤷ Get Started Free | Patent Expiration: | May 1, 2033 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
Expired US Patents for NDA 205065
Complete Access Available with Subscription
